WCMNY
ABBV icon

Westchester Capital Management (New York)’s AbbVie ABBV Stock Holding History

Westchester Capital Management (New York)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-50,500
Closed -$2.09M – 112
2013
Q2 		$2.09M Buy
+50,500
New +$2.21M 0.04% 112

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Westchester Capital Management (New York)'s ABBV Position: Q3 2013 in Review

Westchester Capital Management (New York) sold out of AbbVie (ABBV) in Q3 2013, closing a stake of 50,500 shares — an estimated $2.09M sold.

Westchester Capital Management (New York) first reported a position in ABBV in Q2 2013 and held it in 1 quarter. The position peaked at $2.09M in Q2 2013. 1,297 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

  • Westchester Capital Management (New York) reported no remaining AbbVie position as of Q3 2013 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 50,500 AbbVie shares in Q3 2013, an estimated $2.09M.
  • Westchester Capital Management (New York) first reported a position in AbbVie in Q2 2013 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s AbbVie position peaked at $2.09M in Q2 2013.
  • 1,297 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2013, filed 14 Nov 2013.